Assessment of Arabian Gulf Seaweeds from Kuwait as Sources of Nutritionally Important Polyunsaturated Fatty Acids (PUFAs)

Bioactive Compounds of Marine Algae and Their Potential Health and Nutraceutical Applications: A Review

Currently, marine algae are still an under-exploited natural bioresource of bioactive compounds. Seaweeds represent a sustainable source for obtaining bioactive compounds that can be useful for the fabrication of new active products with biomedical benefits and applications as biomedicinals and nutraceuticals. The objective of this review is to highlight scientific papers that identify biocompounds from marine macroalgae and emphasize their benefits. The method used was data analysis to systematize information to identify biocompounds and their various benefits in pharmaceuticals, cosmetics, and nutraceuticals. The research results demonstrate the multiple uses of seaweeds. As pharmaceuticals, seaweeds are rich sources of bioactive compounds like polysaccharides, protein compounds, pigments, and polyphenols, which have demonstrated various pharmacological activities such as antioxidant, antibacterial, anti-inflammatory, antiviral, anticoagulant, and potentially anticarcinogenic effects. Seaweed has gained recognition as a functional food and offers a unique set of compounds that promote body health, including vitamins, minerals, and antioxidants. In conclusion, the importance of this review is to expand the possibilities for utilizing natural resources by broadening the areas of research for human health and marine nutraceuticals.

Photobiota of the Tropical Red Sea: Fatty Acid Profile Analysis and Nutritional Quality Assessments

Photosynthetic organisms are primary sources of marine-derived molecules, particularly ω3 fatty acids (FAs), which influence the quality of marine foods. It is reported that tropical organisms possess lower FA nutritional quality than those from colder oceans. However, the high biodiversity known for tropical areas may help compensate for this deficiency by producing a high diversity of molecules with nutritional benefits for the ecosystem. Here we addressed this aspect by analyzing the FA profiles of 20 photosynthetic organisms from the salty and warm Red Sea, a biodiversity hot spot, including cyanobacteria, eukaryotic microalgae, macroalgae, mangrove leaves, as well as three selected reef's photosymbiotic zooxanthellate corals and jellyfish. Using direct transesterification, gas chromatography-mass spectrometry, FA absolute quantification, and nutritional indexes, we evaluated their lipid nutritional qualities. We observed interspecific and strain-specific variabilities in qualities, which the unique environmental conditions of the Red Sea may help to explain. Generally, eukaryotic microalgae exhibited the highest nutritional quality. The previously unanalyzed diatoms Leyanella sp. and Minutocellus sp. had the highest eicosapentaenoic acid (EPA) contents. The bioprospected Red Sea photobiota exhibited pharmaceutical and nutraceutical potential. By sourcing and quantifying these bioactive compounds, we highlight the untapped rich biodiversity of the Red Sea and showcase opportunities to harness these potentials.

Mechanism of up-regulated H2O2 BPA-derived production and production of (poly)phenols by two seaweeds of the genus Ulva

The present study provides information on the effects of BPA on ROS production-related phenomena in the chlorophytes Ulva rigida and U. intestinalis, and on the mechanism they establish against BPA toxicity, at environmentally relevant concentrations (0.1-3 μg L-1). Up-regulated H2O2 generation seems to be a key factor causing oxidative damage. Interspecific differences, in terms of the mechanism and the temporal response to BPA toxicity were observed. BPA effects on U. rigida were more intense and appeared earlier (on 1D at 0.1 μg L-1) compared to U. intestinalis and mostly after 7D (LOEC: 0.3 μg L-1, Terminal time, Tt: 7D). In U. rigida, on 1-5D, the 'mosaic' type effect patterns ('models' 3A/3B) with 'unaffected' and 'affected' areas (dark content, positive H2DCF-DA staining signal/H2O2 production and chlorophyll autofluorescence signal loss) indicated a time-dependent manner. After 7D, only U. rigida cells with dark content formed aggregates, showing positive H2O2 production ('model' 4) or in some cells oxidative damages triggering retrograde signaling in the neighboring 'unaffected' areas ('model' 5). H2O2 overproduction (CTCF ratio) in U. rigida, on 1D at the lowest concentration and after 7D at 0.3-1/3 μg L-1, respectively, seems to stimulate (poly)phenolic production, in a dose- and time-dependent manner. U. intestinalis did not display severe BPA impact (i.e., 'models' 4, 5) at any exposures, although at a later time indicated a lower LOEC (0.1 μg L-1, Tt: 9D) than that in U. rigida. In U. intestinalis, H2O2 production does not appear to stimulate high (poly)phenolic amounts.

Seaweeds in Food: Current Trends

Edible seaweeds are an excellent source of macronutrients, micronutrients, and bioactive compounds, and they can be consumed raw or used as ingredients in food products. However, seaweeds may also bioaccumulate potentially hazardous compounds for human health and animals, namely, heavy metals. Hence, the purpose of this review is to analyze the recent trends of edible seaweeds research: (i) nutritional composition and bioactive compounds, (ii) the use and acceptability of seaweeds in foodstuffs, (iii) the bioaccumulation of heavy metals and microbial pathogens, and (iv) current trends in Chile for using seaweeds in food. In summary, while it is evident that seaweeds are consumed widely worldwide, more research is needed to characterize new types of edible seaweeds as well as their use as ingredients in the development of new food products. Additionally, more research is needed to maintain control of the presence of heavy metals to assure a safe product for consumers. Finally, the need to keep promoting the benefits of seaweed consumption is emphasized, adding value in the algae-based production chain, and promoting a social algal culture.

Seasonal Changes in the Biochemical Composition of Dominant Macroalgal Species along the Egyptian Red Sea Shore

Macroalgae are significant biological resources in coastal marine ecosystems. Seasonality influences macroalgae biochemical characteristics, which consequentially affect their ecological and economic values. Here, macroalgae were surveyed from summer 2017 to spring 2018 at three sites at 7 km (south) from El Qusier, 52 km (north) from Marsa Alam and 70 km (south) from Safaga along the Red Sea coast, Egypt. Across all the macroalgae collected, Caulerpa prolifera (green macroalgae), Acanthophora spicifera (red macroalgae) and Cystoseira myrica, Cystoseira trinodis and Turbinaria ornata (brown macroalgae) were the most dominant macroalgal species. These macroalgae were identified at morphological and molecular (18s rRNA) levels. Then, the seasonal variations in macroalgal minerals and biochemical composition were quantified to determine the apt period for harvesting based on the nutritional requirements for commercial utilizations. The chemical composition of macroalgae proved the species and seasonal variation. For instance, minerals were more accumulated in macroalgae C. prolifera, A. spicifera and T. ornata in the winter season, but they were accumulated in both C. myrica and C. trinodis in the summer season. Total sugars, amino acids, fatty acids and phenolic contents were higher in the summer season. Accordingly, macroalgae collected during the summer can be used as food and animal feed. Overall, we suggest the harvesting of macroalgae for different nutrients and metabolites in the respective seasons.

Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review

Chronic, low-grade inflammation is linked to the development of non-communicable diseases, including cancer, cardiovascular disease, obesity, insulin resistance, diabetes, and others which together contribute to more than 50% of deaths globally. Modulation of inflammatory responses may be a promising strategy, and n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) may offer a new therapeutic option in inflammatory conditions. Seaweeds are characterised by high nutritional quality and are a good source of many bioactive compounds, including n-3 LC-PUFA. This review addresses the potential anti-inflammatory properties of seaweed derived lipids, and their immunomodulating mechanisms in order to identify the possible applications of seaweed as an anti-inflammatory functional food ingredient or dietary supplement. A few studies have evaluated the anti-inflammatory activity of seaweed lipids using crude lipid extracts, lipid fractions and isolated complex lipids from several seaweeds belonging to the Ochrophyta and Rhodophyta phyla, with only three Ulva rigida, Ulva sp. and Codium tomentosum within the Chlorophyta phylum. It was reported that seaweed derived lipids suppress inducible nitric oxide synthase and cyclooxygenase-2 expression and reduce nuclear factor κB p100 and myeloid differentiation primary response 88 protein levels leading to the downregulation of the production of several pro-inflammatory cytokines and nitric oxide. Further investigations are required to unravel the complex mechanisms underlying their preventive action against chronic inflammation and their potential use as a new functional food ingredient and/or health supplement.

An Overview of Potential Seaweed-Derived Bioactive Compounds for Pharmaceutical Applications

Nowadays, seaweeds are widely involved in biotechnological applications. Due to the variety of bioactive compounds in their composition, species of phylum Ochrophyta, class Phaeophyceae, phylum Rhodophyta and Chlorophyta are valuable for the food, cosmetic, pharmaceutical and nutraceutical industries. Seaweeds have been consumed as whole food since ancient times and used to treat several diseases, even though the mechanisms of action were unknown. During the last decades, research has demonstrated that those unique compounds express beneficial properties for human health. Each compound has peculiar properties (e.g., antioxidant, antimicrobial, antiviral activities, etc.) that can be exploited to enhance human health. Seaweed's extracted polysaccharides are already involved in the pharmaceutical industry, with the aim of replacing synthetic compounds with components of natural origin. This review aims at a better understanding of the recent uses of algae in drug development, with the scope of replacing synthetic compounds and the multiple biotechnological applications that make up seaweed's potential in industrial companies. Further research is needed to better understand the mechanisms of action of seaweed's compounds and to embrace the use of seaweeds in pharmaceutical companies and other applications, with the final scope being to produce sustainable and healthier products.